share_log

JonesTrading Initiates Coverage On Acrivon Therapeutics With Buy Rating, Announces Price Target of $26

JonesTrading Initiates Coverage On Acrivon Therapeutics With Buy Rating, Announces Price Target of $26

JoneStrading以買入評級開始對Acrivon Therapeutics進行報道，宣佈目標股價爲26美元
Benzinga ·  2023/08/18 17:16

JonesTrading analyst Soumit Roy initiates coverage on Acrivon Therapeutics (NASDAQ:ACRV) with a Buy rating and announces Price Target of $26.

瓊恩斯交易分析師Soumit Roy以買入評級啟動對阿裡馮治療公司(納斯達克：ACRV)的報道，並宣佈目標價為26美元。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論